NCT01163019

Brief Summary

Background: Chest pain (CP) and suspected heart attack is the second most frequent complaint among patients presenting to the emergency department (ED). Present workup involves in-hospital observation for 6 - 48 hours and requires significant resources including imaging tests, some of which are invasive and involve radiation and radio-contrast agents, which can be toxic to the kidney. CP can result from impaired blood supply to the heart muscle, which may result in impaired contraction of the heart that persists for several days. Bedside echocardiography with semi-automated speckle tracking strain analysis (2D strain) is a novel promising noninvasive tool for the evaluation of heart muscle contraction. 2D strain can be useful for evaluating patients with CP, since it can accurately detect minor impairment in heart muscle contraction that can identify patients with coronary artery disease (CAD) and impending heart attack (coronary arteries are the arteries supplying blood to the heart muscle). Working hypothesis and aims: The investigators hypothesize that a bedside echo study with normal 2D strain may allow quick and safe ruling out of a heart attack and significant CAD disease as the cause of CP. The main aim of the study is to validate the investigators preliminary findings in a large number of patients in order to establish whether a normal 2D strain can safely rule out a heart attack or life threatening CAD. Methods: In a large multi-center study 1200 patients presenting to the ED with acute CP of an unclear cause will undergo echocardiography as close as possible to presentation and not more than 24 hours from cessation of pain. Patients will undergo standard workup by the ED physicians. Standard echocardiographic findings, but not the 2D strain analysis, will be made available to the attending physician. Data from discharge letters, ECGs, blood tests, stress tests, nuclear imaging, heart CT and heart catheterization will be collected. A 6-month follow-up telephone interview will be performed to collect data on survival, heart attacks, re-hospitalization and revascularization (opening heart vessels blockages). 2D strain analysis will be performed off-line in a central laboratory to evaluate the ability of 2D strain to distinguish between patients with CP from heart disease and patients without life threatening heart disease that can be early released home safely. Expected results: The investigators expect, based on the investigators previous experience, that patients with normal 2D strain will have a very low probability of a heart attack and significant CAD. The investigators further expect these patients to have an excellent 6-month prognosis. This will allow their early and cost-effective discharge. Importance and Probable implications to Medicine: Reduction in ED patient load and a decrease in unnecessary hospitalizations for CP. Cost and resource savings and elimination of unnecessary imaging studies, some of which are invasive or involve radiation and contrast agents.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2010

Longer than P75 for all trials

Geographic Reach
1 country

11 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 15, 2010

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2010

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

October 28, 2014

Status Verified

October 1, 2014

Enrollment Period

3.4 years

First QC Date

July 12, 2010

Last Update Submit

October 27, 2014

Conditions

Keywords

Chest painacute coronary syndromeEmergency departmentspeckle tracking imaging2D strainEchocardiography

Outcome Measures

Primary Outcomes (2)

  • Acute coronary syndrome

    1 week

  • Significant coronary artery disease.

    1 week

Secondary Outcomes (1)

  • Major adverse cardiac events (MACE - death, MI or revascularization)

    6 months

Study Arms (1)

Chest pain

Patients who present to the emergency department with a chief complaint of chest pain and have a moderate pre-test probability for an acute coronary syndrome

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients presenting to the emergency department with a chief complaint of chest pain

You may qualify if:

  • Patients presenting to the emergency department with chest pain characteristic for ischemia and suspected acute coronary syndrome and at least one of the following:
  • Planned emergency department or chest pain unit observation for at least 6 hours
  • Hospital or chest pain unit admission for suspected acute coronary syndrome
  • Planned coronary CT scan
  • Age ≥ 45 years old
  • Normal sinus rhythm
  • Patient able to give an informed consent

You may not qualify if:

  • ST elevation MI (≥ 1mm in at least 2 contiguous leads) or unstable patients requiring urgent care
  • Significant (≥ 1mm ST depression in at least 2 contiguous leads) on initial ECG
  • Elevated troponin on first examination
  • History of previous MI, CABG, significant Q waves on ECG or wall motion abnormality on a previous echo
  • Atrial fibrillation or abundant arrhythmia
  • CLBBB, Ventricular pacing
  • Valvular disease of at least moderate severity
  • Cardiomyopathy
  • Abnormal septal motion due to right ventricular disease or lung disease
  • Technically suboptimal echo study (\> 2 segments of suboptimal quality from apical views)
  • Pregnancy
  • Inadequate strain tracing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Ha'Emek Medical Center,

Afula, Israel

Location

Soroka University Medical Center

Beersheba, Israel

Location

Hillel Yafe Medical Center

Hadera, Israel

Location

Lady Davis Carmel Medical Center

Haifa, Israel

Location

Hadassah-Hebrew University Medical Center, Mount Scopus

Jerusalem, Israel

Location

Hadassah-University Medical Center, Ein Kerem

Jerusalem, Israel

Location

Shaare Zedek Medical Center

Jerusalem, Israel

Location

Rabin Medical Center

Petah Tikva, Israel

Location

Kaplan Medical Center

Rehovot, Israel

Location

Chaim Sheba Medical Center

Tel Litwinsky, Israel

Location

Assaf Harofeh Medical Center

Zrifin, Israel

Location

Related Publications (2)

  • Shiran A, Blondheim DS, Shimoni S, Jabarren M, Rosenmann D, Sagie A, Leibowitz D, Leitman M, Feinberg MS, Beeri R, Adawi S, Asmer I, Ganaeem M, Friedman Z, Liel-Cohen N. Effect of image quality on accuracy of two-dimensional strain echocardiography for diagnosing ischemic chest pain: a 2DSPER multicenter trial substudy. Int J Cardiovasc Imaging. 2019 Apr;35(4):617-625. doi: 10.1007/s10554-018-1495-x. Epub 2018 Nov 14.

  • Shiran A, Blondheim DS, Shimoni S, Jabarren M, Rosenmann D, Sagie A, Leibowitz D, Leitman M, Feinberg M, Beeri R, Adawi S, Shotan A, Goland S, Bloch L, Kobal SL, Liel-Cohen N. Two-dimensional strain echocardiography for diagnosing chest pain in the emergency room: a multicentre prospective study by the Israeli echo research group. Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):1016-1024. doi: 10.1093/ehjci/jew168.

MeSH Terms

Conditions

Chest PainCoronary Artery DiseaseAcute Coronary SyndromeEmergencies

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCoronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesDisease AttributesPathologic Processes

Study Officials

  • Avinoam Shiran, MD

    Lady Davis Carmel Medical Center, Technion, Israel Institute of Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Echocardiography, Lady Davis Carmel Medical Center

Study Record Dates

First Submitted

July 12, 2010

First Posted

July 15, 2010

Study Start

September 1, 2010

Primary Completion

February 1, 2014

Study Completion

September 1, 2014

Last Updated

October 28, 2014

Record last verified: 2014-10

Locations